适应性癌症治疗中的门意识
MingYi Wang1, Jacob G Scott2, Alexander Vladimirsky3
1Center for Applied Mathematics, Cornell University, Ithaca, New York, United States of America.
PLoS computational biology
|June 14, 2024
概括
这项研究引入了一种适应性癌症治疗的新方法,该方法可以解释随机瘤进化. 该方法优化治疗计划,在设定的成本预算内最大限度地提高成功概率,改善结果并减少药物使用.
科学领域:
- 在瘤学瘤学.
- 数学生物学 数学生物学
- 计算科学 计算科学
背景情况:
- 适应性癌症治疗整合了进化动态,但往往忽视了随机性.
- 异质瘤中的随机扰动会影响治疗政策的执行.
- 现有的模型很少解释癌症进化的随机性质.
研究的目的:
- 在随机瘤动态下开发一种有效的方法来选择最佳的适应性癌症治疗政策.
- 在定义的成本预算内最大限度地实现治疗目标 (稳定或根除) 的概率.
- 为了解决治疗成本的随机性质,包括药物量和治疗持续时间.
主要方法:
- 使用了一种新的随机最佳控制配方.
- 应用动态编程来获得"值意识"的最佳治疗政策.
- 开发了一种高效的算法,用于计算各种预算门的政策.
主要成果:
- "值意识"政策显著提高了在预算限制下治疗成功的概率.
- 与确定性方法相比,优化政策与整体药物使用率较低相关.
- 该方法在使用随机癌症模型的说明性示例中证明了其有效性.
结论:
- 提出的方法为优化适应性癌症疗法提供了一个强大的框架,考虑到进化的随机性.
- 这种方法为平衡治疗效率与癌症护理成本限制提供了有价值的工具.
- 它提高了适应性治疗策略的可靠性,面对不可预测的瘤进化.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


